SCHEMBL8007591

SCHEMBL8007591

COC(=O)Oc1cc(C)c(C[C@H](N)C(=O)N2CCCc3cc(OC)ccc32)c(Br)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.53
OPRD1 P41143 3/20 0.53
OPRK1 P41145 3/20 0.53
HSD17B10 Q99714 1/20 0.52
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
PDK1 Q15118 1/20 0.43
PDK2 Q15119 1/20 0.43
PDK3 Q15120 1/20 0.43
PDK4 Q16654 1/20 0.43
NOTUM Q6P988 1/20 0.42
POLB P06746 3/20 0.41
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 4/20 0.40
TP53 P04637 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8019357 1.00 OPRM1 (0.53) OPRM1OPRD1OPRK1HSD17B10CA1
SCHEMBL8019353 1.00 OPRM1 (0.53) OPRM1OPRD1OPRK1HSD17B10CA1
SCHEMBL8017648 0.95 OPRM1 (0.50) OPRM1OPRD1OPRK1HSD17B10CA1
SCHEMBL8017646 0.95 OPRM1 (0.50) OPRM1OPRD1OPRK1HSD17B10CA1
SCHEMBL8017665 0.95 OPRM1 (0.50) OPRM1OPRD1OPRK1HSD17B10CA1
SCHEMBL8017144 0.94 OPRM1 (0.59) OPRM1OPRD1OPRK1HSD17B10CA1
SCHEMBL8017327 0.94 OPRM1 (0.56) OPRM1OPRD1OPRK1HSD17B10CA1
SCHEMBL8024091 0.94 OPRM1 (0.56) OPRM1OPRD1OPRK1HSD17B10CA1
SCHEMBL8021437 0.94 OPRM1 (0.59) OPRM1OPRD1OPRK1HSD17B10CA1
SCHEMBL8017147 0.94 OPRM1 (0.59) OPRM1OPRD1OPRK1HSD17B10CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6114381-A TO CONTROL BRAIN DAMAGE ASSOCIATED WITH ANOXIA OR ISCHEMIA WHICH TYPICALLY FOLLOWS STROKE, CARDIAC ARREST OR PERINATAL ASPHYXIA; COMPOUND IS AN ANTAGONIST TO INHIBIT EXCITOTOXIC ACTIONS AT EXCITATORY AMINO ACID RECEPTOR SITES G. D. SEARLE & CO. (US) 2000-09-05 US disclosed